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RESEARCH ARTICLE
Piscine orthoreovirus infection 
in Atlantic salmon (Salmo salar) protects 
against subsequent challenge with infectious 
hematopoietic necrosis virus (IHNV)
Niccoló Vendramin1* , Anna Luiza Farias Alencar1, Tine Moesgaard Iburg1, Maria Krudtaa Dahle2, 
Øystein Wessel3, Anne Berit Olsen2, Espen Rimstad3 and Niels Jørgen Olesen1
Abstract 
Infectious hematopoietic necrosis virus (IHNV) is endemic in farmed rainbow trout in continental Europe and in vari-
ous salmonid fish species at the Pacific coast of North America. IHN has never occurred in European Atlantic salmon 
(Salmo salar) farms, but is considered as a major threat for the European salmon industry. Another virus, Piscine 
orthoreovirus (PRV), is widespread in the sea phase of Atlantic salmon, and is identified as the causative agent of heart 
and skeletal muscle inflammation. The aim of this study was to investigate the interactions between a primary PRV 
infection and a secondary IHNV infection under experimental conditions. A PRV cohabitation challenge was per-
formed with Atlantic salmon. At peak of PRV viremia the fish were challenged by immersion with an IHNV genogroup 
E isolate. Clinical signs and morbidity were monitored. Target organs were sampled at selected time points to assess 
viral loads of both pathogens. Antiviral immune response and presence of histopathological findings were also inves-
tigated. Whereas the PRV-negative/IHNV positive group suffered significant decrease in survival caused by IHNV, the 
PRV infected groups did not suffer any morbidity and showed negligible levels of IHNV infection. Antiviral response 
genes were induced, as measured in spleen samples, from PRV infected fish prior to IHNV challenge. In conclusion, 
PRV-infection protects Atlantic salmon against IHNV infection and morbidity, most likely by inducing a protective 
innate antiviral response.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Viral pathogens constantly challenge finfish aquaculture. 
In net pens, farmed stocks can be exposed to pathogens 
through water at any given time. Therefore, knowledge 
about effects of co-infections and pathogen interactions 
is important for development and implementation of 
effective disease control strategies.
Infectious hematopoietic necrosis virus (IHNV) is a 
member of the Rhabdoviridae family, genus Novirhab-
dovirus, which are bullet shaped viruses with non-seg-
mented, negative single stranded RNA genome. IHNV 
is the causative agent of infectious hematopoietic necro-
sis (IHN), a widespread disease mainly found in salmo-
nid fish species in western North-America, continental 
Europe and Asia [1]; IHN belongs to the list of notifiable 
listed disease according to current legislation [2]. Clini-
cally affected fish externally show the skin darkening, 
exophthalmia and pale gills. Common necropsy findings 
are pale internal organs with petechial hemorrhages, and 
intestines often filled with mucus-like fluid [3].
Phylogenetic analyses of the genetically diverse G gene 
of IHNV define five major genogroups (U, M, L, E, J), 
which broadly refer to the geographical distribution of 
the genogroups [3, 4].
The presence of IHNV in Europe was first confirmed in 
1987, with at least two different introductions in Italy and 
France, with viruses originating from the M genogroup. 
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Since then, IHNV has spread in different European coun-
tries, evolving separately and constituting the E geno-
group which is the youngest within IHNV genogroups 
[5]. IHNV is currently endemic in continental Europe 
and can be associated with significant losses in fresh-
water farmed rainbow trout (Onchorynchus mykiss), 
while countries producing Atlantic salmon in northern 
Europe are declared officially free from the virus accord-
ing to European legislation [2]. The virus is widespread 
in western North-America, including seawater areas with 
Atlantic salmon farming, where a DNA vaccine is used to 
control the disease [6]. In the seawater phase both Pacific 
salmonid species and Atlantic salmon are susceptible to 
infection [7].
Piscine orthoreovirus (PRV) is ubiquitous in farmed 
salmon in Norway during the sea water phase, and has 
emerged in recent years as a relevant threat for Atlan-
tic salmon aquaculture being the etiological agent of 
heart and skeletal muscle inflammation (HSMI) [8–12]. 
PRV is a non-enveloped virus with a segmented double-
stranded RNA genome enclosed in a capsid with two 
concentric protein layers [13], currently PRV cannot be 
cultivated in vitro un cell culture monolayers. The gross 
pathological findings of HSMI point towards circula-
tory failure, and characteristic histopathological findings 
are epi-, endo- and myocarditis, myocardial necrosis, 
red skeletal myositis and necrosis [14]. PRV infection in 
Atlantic salmon induces a strong innate antiviral immune 
response in its major target cell, the erythrocyte [15], and 
thus this response can be measured in any vascularized 
organ, and has been described in various organs such as 
spleen, head kidney and heart tissue [10, 16].
In this study, we show that a preceding PRV infection 
in Atlantic salmon interferes with a subsequent challenge 
with genogroup E IHNV, fully protecting the fish from 
infection and IHN disease development. The experiment 
also demonstrated the susceptibility of Atlantic salmon 
for IHNV, genogroup E.
Materials and methods
Experimental design and fish sampling
The experiments were carried out in the facilities at 
DTU-VET (Frederiksberg, Denmark) in accordance with 
the recommendations in the current animal welfare regu-
lations under the license 2013-15-2934-00976. The pro-
tocols were approved by the Danish Animal Research 
Authority.
The fish were monitored on a daily basis regarding state 
of health and environment.
Atlantic salmon juveniles (mean weight of 5  g) were 
imported from a commercial farm certified free from 
listed diseases according to EU legislation (CD 2006/88) 
also including infectious pancreatic necrosis virus 
(IPNV) and bacterial kidney disease (BKD). The fish were 
brought into the quarantine facility, using recirculated 
tap water disinfected by UV, temperature = 12  °C ± 1, 
and kept there for 75 days. Before starting the trial, the 
experimental fish were screened for IHNV, IPNV and 
viral haemorrhagic septicemia virus (VHSV) inoculating 
organ homogenate on cell culture according to a Council 
implementing decision 2015-1554 [17]. Furthermore, fish 
were screened by qPCR for salmonid alphaviruses (SAV), 
according to OIE Manual of Diagnostic Tests for Aquatic 
Animals [18] and PRV [9]. Bacteriological analysis was 
performed according to standard diagnostic procedures, 
by streaking kidney tissue onto blood agar (BA) and 
Tryptone Yeast Extract Salts (TYES), followed by incuba-
tion for 1 week at 20 and 15 °C, respectively. All tests for 
all pathogens were negative prior to the infection trial.
An overview of the experimental design is displayed in 
Figure 1. After the quarantine period and health screen-
ing, 570 Atlantic salmon (Salmo salar L.) (mean weight 
15  g) were transferred to the experimental facilities 
at DTU-VET and separated into six tanks (150  L tanks 
(Table  1) run with 15  L/h flow-through fresh water 
renewal at the following conditions: 12  °C ± 1  °C, L:D 
12:12, stocking density below 70  kg/m3, and feeding of 
1.5% of biomass.
For the pathogenesis study the 150  L tanks of each 
group PRV−/IHNV+, PRV+/IHNV+, PRV−/IHNV−, 
and PRV+/IHNV− were repeatedly sampled to monitor 
virus kinetics and antiviral responses. To study patho-
genicity, duplicate tanks of the groups PRV−/IHNV+ 
and PRV+/IHNV+ (20 fish per group) were transferred 
to small bowls (8  L) upon IHNV challenge and moni-
tored for clinical signs, disease development and mortal-
ity for 45 days.
Prior to organ sampling, fish were anesthetized with 
benzocaine chloride (800 mg/1 L water) and euthanized 
by cervical transection. During the first 4 weeks post PRV 
challenge, blood, spleen and heart samples were taken 
weekly from two shedders and two cohabitants from PRV 
exposed and non-exposed tanks (tanks 3–6). Weight and 
length of each animal were recorded.
In the second part of the trial, i.e. after the IHNV chal-
lenge, three shedders and three cohabitants from each of 
the 150  L tanks (2, 4, 5 and 6) were sampled more fre-
quently, i.e. at 2, 5, 12, 19, 26 and 33  days post IHNV 
infection. During this latter phase, head kidney was 
added to the sampling sets. Spleen and head kidney were 
stored in  RNALater® (ThermoFisher Scientific Inc, USA). 
Hearts were divided along the midsagittal line, storing 
one part in  RNALater® (ThermoFisher Scientific Inc) and 
the other in 10% buffered formalin for histopathological 
assessment. Blood was sampled from the caudal vein on 
heparinized tubes (BD Biosciences, USA) and aliquoted 
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for both hematocrit and hemoglobin evaluation in a 
Hematology Analyzer (Vet ABC, Scil, USA) and to pre-
pare blood smears for immunofluorescence staining. The 
experiment was terminated 45 days after IHNV challenge 
(corresponding to 73 days after PRV challenge).
Challenge trials
PRV cohabitation challenge
The PRV inoculum used for infection originated from 
a field outbreak of HSMI in Norway in 2012 that had 
subsequently been passaged in three PRV challenge 
experiments at VESO Vikan (Oslo, Norway) in which 
HSMI was reproduced [19]. Briefly, heparinized blood 
was collected from three PRV infected fish 7 weeks post 
cohabitation challenge. Blood was centrifuged to remove 
plasma and the remaining blood pellet was pooled and 
diluted 1:3 in Leibovitz’s L15 medium (Life Technolo-
gies, USA) supplemented with gentamicin at 50  μg/mL 
(Gibco, USA) and Fungizone at 0.25  g/mL (Gibco). The 
pellet kept on ice was sonicated ten times for 10 s each at 
20 kHz and centrifuged at 2000 × g. The resulting super-
natant was shown to contain high loads of PRV as deter-
mined by RT-qPCR (Ct value of 18.6/5 µL inoculum).
Fish dedicated to be shedders (n = 40 per tank) were 
injected intra-peritoneal (i.p.) with 0.1  mL of challenge 
material under anesthesia with benzocaine (80  mg/L) 
and marked by clipping of the adipose fin. Fifty-five naïve 
unmarked cohabitants were added to each tank, resulting 
in a shedder ratio of 42%.
In PRV negative tanks shedders were mock injected 
with 0.1 mL of naïve rainbow trout blood (tested negative 
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Figure 1 Experimental design. After acclimation and health screening (1), Atlantic salmon parr were divided in 6 × 150 L tanks and PRV cohabi-
tation challenge was performed. Each tank contained each 40 shedders or mock-shedders (controls) and 55 cohabitants (2). After monitoring PRV 
infection for 4 weeks (3), IHNV bath challenge was performed (4). At this stage 32 shedders and 47 cohabitants were present in each tanks. The trial 
continued for 45 days after IHNV trial. (5) Sampling at selected time points continued in large tanks, while pathogenicity assessment was conducted 
in duplicate small 8 L bowls (10 shedders and 10 cohabitants) (tanks 1a, b and 3a, b).
Table 1 Prevalence of hearts with lesions consistent 
with HSMI
Treatment Shedders Cohabitants Total
Positive/n Positive/n Positive/n
Negative control – – 0/17
PRV−/IHNV+ – – 0/21
PRV+/IHNV− 16/20 16/21 32/41 (78%)
PRV+/IHNV+ 18/21 14/21 32/42 (76%)
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for PRV by RT-qPCR) prepared like the PRV infected 
inoculum.
IHNV immersion challenge
Four weeks post PRV infection, upon the peak of PRV 
viremia (median PRV Ct value obtained in cohabit-
ants = 19.8), IHNV challenge was performed in tanks 1, 
2, 3 and 4. Before IHNV challenge 40 fish from each of 
the duplicate tanks 1 and 3 (PRV−/IHNV+ and PRV+/
IHNV+) were transferred to 8 L bowls (20 fish in each, 
i.e. 10 PRV shedders and 10 PRV cohabitants). In order 
to maintain the same biomass during the challenge time 
(3 h) fish from tanks 2 and 4 were transferred into 30 L 
tanks for the IHNV challenge, and then transferred back 
in the original 150 L tanks. Remaining fish from tank 1 
and 3 were excluded from the trial.
For IHNV challenge, the German isolate DF04/99, 
proven to be highly virulent to rainbow trout [20] was 
propagated in EPC (Epithelioma Papulosum Cyprini, 
 ATCC® C RL-2872™) cell monolayers at 15  °C, frozen 
once and titrated (Kärber method) [21] in EPC cells. 
IHNV immersion challenge dose was estimated as  106 
 TCID50/mL, whereas fish from tank 5 and 6 where mock 
challenged with sterile L15 media. Fish were challenged 
for a period of 3 h.
Fish separated into the bowls for the pathogenicity 
study were monitored daily for clinical signs of disease. 
Individual fish displaying clinical signs of IHN (apathy, 
skin darkening, exophthalmos and abnormal behavior) 
were euthanized by an overdose of benzocaine chloride 
(500 mg/L). Head kidney, heart and spleen from clinically 
affected fish were sampled and pooled in MEM (Mini-
mum Essential Medium, Sigma Aldrich, USA) following 
the criteria of one pool per bowl per day, for later confir-
mation of IHNV infection by RT-qPCR.
RT‑qPCR for assessing viral loads
RT-qPCR was performed on RNA purified from spleen. 
Total RNA was purified using Qiagen RNeasy mini kit 
(QIAGEN, Germany) and the final RNA eluted in 30 µL 
of RNAse free water. RNAse free water was used as a 
negative control and positive blood sample was used as a 
positive control.
RT-qPCR was carried out using QuantiTect Probe 
RT-PCR Kit (QIAGEN), according to the manufactur-
er’s instructions. Briefly, for each sample, 5  µL of puri-
fied RNA was mixed with 4.75 µL of RNAse free water; 
12.5  µL of 2X QIAGEN Quantitect Probe Mix; 1 µL of 
each primer at 10  µM; 0.5  µL of the probe and 0.25  µL 
of QIAGEN Quantitect Enzyme Mix. RNAse free water 
was used as a negative control. Primers, probes and 
working conditions for RT-qPCR for PRV and IHNV are 
described elsewhere [9, 22].
RT-qPCR was performed on Stratagene Mx3005P and 
Mx3000P qPCR-systems, with MxPro (v. 4.10) software 
used for RT-qPCR data analysis. According to internal 
Standard Operating Procedure cut-off value was set as 
35 Ct, samples with higher Ct values were considered 
doubtful, given sigmoidal shape of related amplification 
plot; otherwise they were considered negative.
Histopathological examination
From day 2 after IHNV challenge heart sections from 122 
fish were assessed by histopathological examination.
Tissue samples stored in 10% neutral buffered formalin 
were embedded in paraffin and routinely processed into 
sections of 3–4  µm thickness, stained with haematoxy-
lin and eosin (H&E) and examined by light microscopy. 
Histopathological changes in the heart consistent with 
HSMI were scored as none or very sparse (0–0.5), mild 
focal (1), mild to moderate multifocal (1.5), moderate dif-
fuse (2) and severe diffuse findings (2.5), modified after 
guidelines previously provided [14] (Figure 5).
Immunofluorescence antibody test (IFAT) for PRV
An immunofluorescence antibody test (IFAT) was per-
formed on blood smears using a polyclonal antibody 
raised in rabbits against the putative PRV outer capsid 
protein ơ1 (anti-ơ1) [23] as described previously [24]. The 
panel of samples included five selected specimens from 
PRV-infected blood collected at the peak of viremia, cho-
sen based on low Ct levels. Uninfected blood samples, i.e. 
negative by RT-qPCR, were used as negative controls.
Immune gene response analysis
A selection of spleen samples from PRV cohabitants 
(n = 3–6 per sampling point) were homogenized indi-
vidually in 500  µL QIAzol Lysis Reagent (QIAGEN) 
with 5  mm steel beads in a TissueLyser II (QIAGEN). 
Total RNA was isolated by chloroform extraction and 
ethanol precipitation and loaded onto an RNeasy mini 
spin column (QIAGEN). Further purification was per-
formed according to the RNeasy kit instructions, and 
the final RNA concentration was measured using a Nan-
oDropTM 2000 spectrophotometer. Total RNA (500 ng) 
from each sample was used for cDNA synthesis using the 
QuantiTect Reverse Transcription kit (QIAGEN) with a 
genomic DNA elimination step. For RT-qPCR analysis, 
cDNA corresponding to 10 ng RNA was analysed in tri-
plets for 40 cycles of 94  °C for 15  s and 60  °C for 30  s. 
Levels of elongation factor 1 α (EF1α), Mx-1, interferon 
(IFN)a and IFNc mRNA were assessed using 500  nM 
forward and reverse primers [25], and the Maxima 
SYBR Green/ROX qPCR Master Mix (Fisher Scientific). 
The specificity of the SYBR Green assay was confirmed 
by melting point analysis. An eight point concentration 
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standard curve (two-fold dilutions) made from a repre-
sentable mix of samples was run on each plate and used 
to calculate relative gene expression differences. Levels of 
EF1α mRNA were used for normalization [12].
Statistics
To compare the differential survival rate, the Kaplan–
Meier estimator was used. Log-rank (Mantel-Cox) test 
was applied to verify the equality of survivor functions 
across groups. To investigate the difference measured in 
haematocrit and haemoglobin levels between the differ-
ent experimental groups One way ANOVA followed by 
Kruskall–Wallis test was performed. All statistical analy-
ses were performed using GraphPad Prism version 6.00 
for Windows, GraphPad Software, La Jolla, California, 
USA).
Results
Protective effect of PRV infection against subsequent IHNV 
challenge
In the pathogenesis trial conducted in the 150 L tanks 2, 
4, 5 and 6, onset of morbidity started as early as 5 days 
post IHNV challenge and reached 7% at the end of the 
trial (data now shown). In the pathogenicity trial con-
ducted in the 8  L bowls, morbidity was observed from 
6  days post IHNV challenge, apart from one fish which 
succumbed on day 1 likely due to handling procedures 
during transfer. Survival rates differed significantly (Log 
Rank Mantel-Cox test p < 0.0001) between the co-chal-
lenged group PRV+ IHNV+ (average survival 97.5% 
SD 2.5%) and PRV− IHNV+ (average survival 50%, SD 
5%) (Figure  2). No morbidity was recorded in PRV+ 
IHNV− tanks, in co-challenged tanks PRV+ IHNV+ 
and negative control tanks. Clinically affected specimens 
showed typical IHN signs such as pale gills, skin dark-
ening, exophthalmia and petechial bleedings in internal 
organs. Presence of IHNV RNA was confirmed by RT-
qPCR as the causative agent of morbidity (Alencar et al., 
in preparation).
Time course detection of PRV and IHNV
PRV infection peaked at 4 weeks post challenge in cohab-
itants, and maintained a persistent plateau phase until 
the end of the infection trial (Figure  3A). Median Ct 
value obtained from spleen samples at the maximum 
level of infection was 19.8 (± 2.2) in cohabitants, and 21.4 
(± 0.46) in shedders. At the last sampling 51  days post 
PRV challenge in PRV+ IHNV−, the median PRV Ct 
value was 23.9 (± 1.03) in cohabitants and 26.1 (± 1.15) in 
the shedders. In the co-challenged group, the median Ct 
value was 24.2 (± 2.2 SD) in cohabitants and 26.6 (± 1.7) 
in shedders. No significant difference in the Ct values was 
observed when comparing the groups (Figure 3A).
IHNV infection kinetics developed as an acute infec-
tion characterized by high viral loads in spleen followed 
by substantial decrease in the PRV− IHNV+ group. 
IHNV RNA was detected in spleen as early as 5  days 
post IHNV challenge (1 of 3 fish tested IHNV positive, 
Ct 24.7); and at day 9, 2 of 3 fish tested IHNV positive (Ct 
25.8 and 21.1). Thereafter, the Ct values and the number 
of positive fish decreased and at the last sampling at day 
33, IHNV RNA was detected at negligible level in only 1 
sample (Ct 39.7).
In the co-challenged group PRV+ IHNV+, IHNV 
RNA was detected at negligible levels in only 1 sample 
throughout the whole experiment, at day 5 post IHNV 
challenge (Ct 38.5) (Figure 3B).
Figure 2 Survival rate of Atlantic salmon in pathogenicity studies. Kaplan–Meier survival curves for the PRV−/IHNV+, PRV+/IHNV+ groups 
describing the pathogenicity study conducted in duplicate 8 L bowls with 20 fish in each unit of the groups.
Page 6 of 12Vendramin et al. Vet Res  (2018) 49:30 
The results obtained by RT-qPCR were corroborated 
corroborated by immunofluorescent detection of PRV 
outer capsid protein σ1 in cytoplasmic and perinuclear 
inclusions of blood cells from (Figure 3C).
Modulation of IFNa, IFNc and Mx expression in PRV 
infected and IHNV co‑challenged fish
Fish challenged with PRV by cohabitation were ana-
lysed for expression of the antiviral genes IFNa, IFNc 
and Mx in spleen (Figure  4). A mean two-fold increase 
in IFNa and a 30 fold increase in Mx expression rela-
tive to expression levels in uninfected fish was observed 
at 4  weeks post PRV challenge, at the time when the 
fish were co-challenged with IHNV. After this, the IFN 
expression continued to increase up to five to sixfold in 
PRV+/IHNV− fish whereas Mx slightly decreased (Fig-
ure  4). In comparison, the co-challenged fish PRV+/
IHNV+ tended to have lower expression of IFN (both a 
and c) and Mx 9 days after IHNV co-infection compared 
to PRV+/IHNV− although these results were not statis-
tically significant.
HSMI prevalence and severity
The histopathological investigation revealed heart lesions 
consistent with HSMI in both the PRV+/IHNV− and 
PRV+/IHNV+ groups with a large proportion of hearts 
affected (78 and 76% respectively) (Table  1, Figure  5 
and Additional file 1). The extent of lesions varied from 
mild (Figure 5B) to severe (Figure 5C). From day 12 post 
IHNV challenge, six of the seven hearts (86%) with the 
Figure 3 Infection kinetics of PRV and IHNV in A. salmon. A PRV established a persistent infection. Challenge with IHNV did not influence 
PRV relative viral loads measured in spleens. Marks represent the median value of Ct obtained for each group at each time point. B IHNV challenge 
resulted in acute infection peaking 9 days post-challenge followed by a rapid decrease of the viral loads in the spleen. Negligible levels of IHNV 
infection are observed in PRV previously challenged fish. Horizontal lines represent the median value of Ct obtained from three individuals for each 
group at each time point. C Perinuclear immunofluorescent staining of PRV σ1 antigen in Atlantic salmon erythrocytes infected with PRV (100×).
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most severe findings were in the PRV+/IHNV− cohab-
itants group. Comparatively, 89% of the PRV+ IHNV+ 
cohabitants fish sampled during the same period showed 
mild to moderate inflammation (Figure 5 and Additional 
file 1). Fish examined in the PRV−/IHNV+ and negative 
control groups had no heart pathology (Figure 5A).
Variations in hematocrit and hemoglobin during infection
Hematocrit (Hct) and hemoglobin (Hgb) measurements 
revealed significant differences (Kruskall–Wallis test 
Hct p < 0.002 and Hgb p < 0.05) when comparing PRV+/
IHNV− and co-challenged PRV+/IHNV+ groups to the 
negative control group PRV−/IHNV− (Figure 6).
Discussion
Salmonid aquaculture worldwide largely relies on pro-
duction in net pens. This production mode introduces a 
risk of potential transfer of pathogens between wild and 
farmed stocks. Wild stocks may harbor several infective 
agents, and farmed fish may act as amplifiers of patho-
gens posing a risk to the wild stocks in the eco-system 
of the farming area. Therefore, knowledge about host–
pathogen interactions and pathogen–pathogen interplay 
is critical for both ecological and economic reasons, and 
thus for the development of a sustainable salmon farming 
industry.
This study brings interesting elements to consider for 
an exhaustive risk assessment analysis of the spread of 
IHNV from continental Europe to Atlantic salmon aqua-
culture industry in northern Europe. The recent report 
from November 2017 (OIE notification) of IHN out-
breaks in rainbow trout in Finland highlights the impor-
tance of such an assessment.
The specific aim was to investigate the effect of PRV 
infection, which is very common in Atlantic salmon in 
Northern Europe, to a subsequent exposure to IHNV, 
belonging to the European genogroup E.
The results showed significant IHNV resistance in PRV 
infected compared to non-PRV infected Atlantic salmon. 
The PRV infected, IHNV challenged fish showed no 
mortality and only negligible levels of IHNV RNA were 
detected. On the contrary, Atlantic salmon not exposed 
to PRV showed clinical signs of IHN such as skin darken-
ing, exophthalmia and lethargy, leading to reduced sur-
vival rate of 93% in 150  L tanks and 50% in 8  L bowls. 
The difference between the survival rates in the two set-
tings can be related to the higher biomass and density in 
this experimental unit (13 kg/m3 in tanks and 70 kg/m3 in 
bowls), as it has been previously reported that host den-
sity is a key factor for the incidence and severity of IHNV 
infections [26].
Our findings are in agreement with the results obtained 
by Lund et  al. [19] where it was demonstrated that a 
Figure 4 Expression of IFNa, IFNc and Mx genes in spleen 
during PRV infection and effect of IHNV co-challenge. Fold 
increase in gene expression of interferon (IFN)a (A), IFNc (B) and the 
IFN− regulated antiviral gene Mx (C) in spleen during the course of 
infection with PRV in Atlantic salmon cohabitants from tank 4 (PRV+/
IHNV+) and tank 5 (PRV+/IHNV−). Gene expression is normalized to 
the reference gene EF1α, and shown as fold induction compared to 
uninfected controls from tank 6 (PRV−/IHNV−).
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preceding PRV infection mediated protection against a 
subsequent SAV challenge, shown by reduction in SAV 
RNA levels and reduced severity of the related patho-
logical lesions. On the other hand, our findings diverge 
considerably from those described by Polinski et al. [27], 
where a PRV challenge conducted in Sockeye salmon 
(Oncorhynchus nerka) using a viral strain from British 
Columbia showed no effect on host immune responses 
or protection against a subsequent IHNV infection. 
However, some significant differences in the two experi-
mental settings may provide explanations for the differ-
ences observed. Firstly, different species were infected in 
100 x 200 x 
A  no inflammation  
  
B  mild inflammation of epicardium and compact and 
spongious myocardum 
  
C  severe inflammation of epicardium and compact and  
spongious myocardum 
  
Figure 5 Grading of histopathological changes related to development of HSMI in A. salmon heart. H&E stained slides. A No inflamma-
tion observed corresponding to grade 0 from (PRV+/IHNV+) co-challenged cohabitant 2 days post-challenge (dpc). IHNV. B Mild inflammation of 
epicardium and compact and spongiousus layer of myocardium corresponding to grade 1 from PRV+/IHNV− challenged shedder 26 dpc IHNV. C 
severe inflammation of epicardium and compact and spongiousus layer of myocardium corresponding to grade “2.5” from PRV+/IHNV− challenged 
cohabitant 19 dpc IHNV.
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the trials; S. salar (this study) and O. nerka in the Polin-
sky study, and different species often show different 
responses to the same pathogen [28, 29]. One example 
of this is that the PRV strain found in rainbow trout in 
Europe cause an HSMI like disease in this species, but 
only affects Atlantic salmon to a minor degree and with 
little induction of antiviral responses [24]. Secondly, the 
PRV challenges were performed differently, since i.p. 
injection of virus was performed in the Sockeye salmon 
challenge, while a cohabitation trial, which better mimics 
natural infection, was used in our Atlantic salmon chal-
lenge. It is also worth reporting that the peak viral load 
was slightly higher in the cohabitant fish than in the i.p. 
injected shedders in our experiment. Thirdly, the Sock-
eye salmon were subjected to IHNV immersion chal-
lenge 2 weeks after PRV injection, while in our study PRV 
infection were allowed to develop for 4 weeks, reaching 
peak viral loads prior to IHNV immersion challenge. 
Figure 6 Haematocrit and haemoglobin levels are reduced by PRV and IHNV infection. Haematocrit levels (A) and haemoglobin levels (B) 
monitored in experimental groups (PRV−/IHNV−, PRV+/IHNV−, PRV−/IHNV+, PRV+/IHNV+) during pathogenesis trial. Mean level and SD from 
the different groups at selected time points are indicated by vertical lines.
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Notably, according to Dahle et al. [15], the peak in PRV 
viral load is correlated with the peak induction of IFN-
regulated antiviral responses in Atlantic salmon blood 
cells. Finally, different viral strains were included in the 
different studies. We used a Norwegian PRV strain shown 
to cause HSMI, whereas the ability of the British Colum-
bia PRV strain to cause disease is not clearly defined yet 
[8, 30]. In regard to IHNV, a European isolate was used in 
this study as part of a targeted risk assessment, whereas 
the American isolate BC93-057, genogroup U was used 
in the study of Polinski [27].
The difference between the IHNV susceptibility of the 
PRV+/IHNV+ group and the PRV−/IHNV+ group was 
striking. The PRV−/IHNV+ showed 50% survival while 
in the co-challenged group all fish survived. This suggests 
that PRV infection is highly protective against the IHNV 
E genogroup, which is well described in terms of pheno-
typic [20] and genetic profile [31]. This finding was cor-
roborated by RT-qPCR analysis assessing the presence 
of PRV and IHNV genome in spleen samples through-
out the experiment. IHNV was detected in most of the 
non-PRV infected fish, depicting the kinetics of an acute 
infection, while IHNV was detected at a very low level 
(Ct 38.5) in only one of the PRV-infected fish.
In agreement with previous studies performed in 
Atlantic salmon [15, 32] PRV induced an increase in 
the gene expression of IFN (IFNa and IFNc) and Mx. In 
general, this immunological pathway is pivotal in pro-
tection against viral infections in vertebrates, includ-
ing Atlantic salmon [33, 34]. In our experiment, PRV 
induced increased IFNa and Mx expression in spleen, 
the organ where PRV-infected erythrocytes are likely to 
accumulate.
In rainbow trout, effective protection from virulent 
novirhabdoviruses is shown to be elicited through the 
IFN response, as indicated by the protective effect of 
a preceding infection with virus such as IPNV, which, 
like PRV, is a non-enveloped dsRNA virus [35, 36]. 
IFN regulated genes are also induced by intramuscu-
lar administration of DNA vaccines against IHNV [37]. 
DNA vaccination against IHNV has proven to give effec-
tive protection already as early as 4  days after injection 
against homologous [38] and heterologous novirhabdovi-
ruses [39], highlighting the importance of innate immune 
responses in protection against novirhabdovirus.
In order to assess the pathological effect of viral chal-
lenge, heart, which is an important target organ for the 
two pathogens, was analysed by histology. The major-
ity of the hearts from fish in both PRV+/IHNV− and 
PRV+/IHNV+ groups developed histopathological find-
ings consistent with HSMI. The lesions varied from mild 
to severe, and there was no difference in the prevalence 
of heart lesions between the two groups. However, an 
interesting trend was observed when scoring the severity 
of the lesions in the two groups, as six out of seven hearts 
with the most severe findings were seen in the hearts 
of PRV+/IHNV− cohabitants group, suggesting that 
exposure to IHNV may possibly modify the host inflam-
matory response to the PRV infection. This observation 
however has to be further investigated.
Interestingly, both PRV and IHNV infection signifi-
cantly affected haematocrit and haemoglobin levels. PRV 
infected fish suffered from significant anaemia (as meas-
ured by both parameters) compared to negative control 
groups at the time of IHNV exposure in the trial, which 
corresponds to the peak in PRV load. Similarly, in the 
PRV−/IHNV+ group, the haemoglobin parameter was 
significantly reduced compared to the control group at 
the end of the experiment, but with largest reduction at 
day 9 post IHNV exposure, i.e. correlating with the peak 
of IHNV infection.
In conclusion, the results show that Atlantic salmon is 
susceptible to the IHNV genogroup E, which is present 
in continental Europe, and that a preceding PRV infec-
tion protects against subsequent IHNV challenge when 
conducted at the peak of PRV viremia. The protection 
observed in this study is likely to be related to the PRV-
induced innate antiviral responses, such as IFN and 
IFN-stimulated genes. Further studies are needed to 
unravel the mechanism behind the observed protection, 
the duration of protection, and its possible specificity 
towards other viral pathogens.
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